Description
Amlexanox is an azoxanthone derivative that is used to treat recurring aphthous ulcer and asthma. Amlexanox alters cytoskeleton function and inhibits cell migration and proliferation through binding to S100A12 and S100A13 proteins and attenuation of actin stress fiber formation and FGF1 release. Amlexanox may exhibit its anti-allergic activity through inhibition of 5- and 12-lipoxygenase, and also through inhibition of histamine release from mast cells. This compound also displays anti-obesity and anti-diabetic properties through its inhibition of TANK-binding kinase 1 (TBK1) and IκB kinase (IKK); this activity increases energy expenditure, thermogenesis, and weight loss, and also improves insulin sensitivity.